scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1018625764 |
P356 | DOI | 10.1186/BCR3632 |
P932 | PMC publication ID | 4053241 |
P698 | PubMed publication ID | 24670297 |
P5875 | ResearchGate publication ID | 261137481 |
P50 | author | JoAnn E. Manson | Q6204013 |
Lewis Kuller | Q88077314 | ||
Rowan T Chlebowski | Q89795128 | ||
Garnet L Anderson | Q37387870 | ||
Shanshan Zhao | Q61832423 | ||
P2093 | author name string | Ross L Prentice | |
Jacques E Rossouw | |||
Sayeh Lavasani | |||
Dorothy S Lane | |||
Thomas E Rohan | |||
Margery Gass | |||
Ruth Patterson | |||
Shirley Aa Beresford | |||
P2860 | cites work | Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial | Q27860743 |
Classification and pharmacology of progestins | Q28244614 | ||
Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial | Q29615226 | ||
The effects of postmenopausal hormone therapy on serum estrogen, progesterone, and sex hormone-binding globulin levels in healthy postmenopausal women | Q33838504 | ||
Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial | Q34208463 | ||
The Women's Health Initiative recruitment methods and results | Q34272010 | ||
Scientific rationale for postmenopause delay in the use of conjugated equine estrogens among postmenopausal women that causes reduction in breast cancer incidence and mortality | Q34362281 | ||
Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy. | Q34512916 | ||
Breast cancer risk in relation to the interval between menopause and starting hormone therapy | Q34577224 | ||
Breast cancer after use of estrogen plus progestin in postmenopausal women | Q34938322 | ||
Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Women's Health Initiative randomised placebo-controlled trial | Q36143058 | ||
Estrogen plus progestin therapy and breast cancer in recently postmenopausal women | Q37163009 | ||
Sex hormone levels and risk of breast cancer with estrogen plus progestin | Q37209551 | ||
Conjugated equine estrogens and breast cancer risk in the Women's Health Initiative clinical trial and observational study | Q37245244 | ||
Estrogen Plus Progestin and Breast Cancer Incidence and Mortality in Postmenopausal Women | Q37480990 | ||
Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials | Q37658616 | ||
Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group | Q39513392 | ||
Design of the Women’s Health Initiative Clinical Trial and Observational Study | Q56483522 | ||
Implementation of the women's health initiative study design | Q57055364 | ||
Projecting individualized probabilities of developing breast cancer for white females who are being examined annually | Q69396132 | ||
Outcomes ascertainment and adjudication methods in the women's health initiative | Q79202519 | ||
P275 | copyright license | Creative Commons Attribution 2.0 Generic | Q19125117 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 2 | |
P304 | page(s) | R30 | |
P577 | publication date | 2014-03-26 | |
P1433 | published in | Breast Cancer Research | Q2208481 |
P1476 | title | Sex hormone associations with breast cancer risk and the mediation of randomized trial postmenopausal hormone therapy effects | |
P478 | volume | 16 |
Q30980873 | Breast Cancer After Use of Estrogen Plus Progestin and Estrogen Alone: Analyses of Data From 2 Women's Health Initiative Randomized Clinical Trials. |
Q30843682 | Covariate measurement error correction methods in mediation analysis with failure time data. |
Q30238978 | Long-term hormone therapy for perimenopausal and postmenopausal women |
Q34315478 | Menopausal hormone therapy and cancer: changing clinical observations of target site specificity |
Q37351543 | Overweight, Obesity, and Postmenopausal Invasive Breast Cancer Risk: A Secondary Analysis of the Women's Health Initiative Randomized Clinical Trials |
Q91637842 | Study on the Antibreast Cancer Mechanism and Bioactive Components of Si-Wu-Tang by Cell Type-Specific Molecular Network |
Q90661837 | The modulation of estrogen-induced apoptosis as an interpretation of the women's health initiative trials |
Search more.